Form D · Pharmaceuticals
MBQ PHARMA INC.
San Juan, PR · CIK 0002148840
Offering snapshot reported Aug 14, 2026 · SEC filing
- Reported sold
- $1.53M Indefinite offering
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 30, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 14, 2026 | Initial | $1,530,000 | No comparison | 8 | SEC filing |
| Aug 14, 2026 | Initial | $882,000 | No comparison | 3 | SEC filing |
| Aug 14, 2026 | Initial | $325,000 | No comparison | 3 | SEC filing |
| Aug 14, 2026 | Initial | $500,000 | No comparison | 2 | SEC filing |
| Aug 14, 2026 | Initial | $991,038 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594328
Source: Form D, filed Aug 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Suranganie Dharmawardhane | Executive |
| Carlos A Dominguez | Director, Executive |
| Arturo Gonzalez | Director |
| Federico Goodsaid | Director |
| Humberto Guzman | Director |
| Eliud Hernandez | Executive |
| Jose F Rodriguez Orengo | Director, Executive |
| Neil Sankar | Executive |
| Cornelis Vlaar | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
998 Ave Luis Munoz Rivera
San Juan, PR, 00927
San Juan, PR, 00927